Molecular characterization of HER2-positive (HER2+) metastatic gastric and gastro-esophageal junction cancer patients (mGC): Identification of resistance mechanisms to trastuzumab-based therapy (TTZ)
Alsina, M., Hierro, C., Sastre, J., Guardeño, R., Lopez, C., Pineda, E., Aranda, E., Manzano, J.L., Galán, M., Longo, F., Visa, L., Landolfi, S., Jimenez, J., Sperinde, J., Pandiella, A., Tabernero, JVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw371.21
Date:
October, 2016
File:
PDF, 43 KB
english, 2016